PA8584201A1 - Mezcla de polisacaridos derivados de heparina, su preparacion y las composiciones farmaceuticas que las contienen - Google Patents

Mezcla de polisacaridos derivados de heparina, su preparacion y las composiciones farmaceuticas que las contienen

Info

Publication number
PA8584201A1
PA8584201A1 PA20038584201A PA8584201A PA8584201A1 PA 8584201 A1 PA8584201 A1 PA 8584201A1 PA 20038584201 A PA20038584201 A PA 20038584201A PA 8584201 A PA8584201 A PA 8584201A PA 8584201 A1 PA8584201 A1 PA 8584201A1
Authority
PA
Panama
Prior art keywords
activity
hexasaccharide
preparation
derived
polyacarids
Prior art date
Application number
PA20038584201A
Other languages
English (en)
Inventor
Vesna Biberovic
Luc Grondard
Pierre Mourier
Christian Viskov
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of PA8584201A1 publication Critical patent/PA8584201A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078Degradation products
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A MEZCLAS DE POLISACARIDOS DERIVADOS DE HAPARINA QUE TIENEN UN PESO MOLECULAR MEDIO DE 1500 A 3000 DALTONS Y UNA RELACION ANTI-XA/ANTI-IIA SUPERIOR A 30, EL PROCEDIMIENTO PARA SU PREPARACION Y LAS COMPOSICIONES FARMACEUTICAS QUE LAS CONTIENEN.
PA20038584201A 2002-10-10 2003-10-01 Mezcla de polisacaridos derivados de heparina, su preparacion y las composiciones farmaceuticas que las contienen PA8584201A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0212584A FR2845686B1 (fr) 2002-10-10 2002-10-10 Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
PA8584201A1 true PA8584201A1 (es) 2004-08-31

Family

ID=32039597

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20038584201A PA8584201A1 (es) 2002-10-10 2003-10-01 Mezcla de polisacaridos derivados de heparina, su preparacion y las composiciones farmaceuticas que las contienen

Country Status (35)

Country Link
EP (1) EP1556414B1 (es)
JP (2) JP5021898B2 (es)
CN (6) CN101812189A (es)
AT (1) ATE548393T1 (es)
AU (1) AU2003300161B2 (es)
BR (1) BR0315149A (es)
CA (1) CA2501546C (es)
CY (1) CY1112808T1 (es)
DK (1) DK1556414T3 (es)
EC (1) ECSP055722A (es)
ES (1) ES2383597T3 (es)
FR (1) FR2845686B1 (es)
GT (1) GT200300181A (es)
HN (1) HN2003000312A (es)
IL (1) IL167868A (es)
MA (1) MA27398A1 (es)
MX (1) MXPA05003321A (es)
MY (1) MY142376A (es)
NI (1) NI200300087A (es)
NO (1) NO20052170L (es)
NZ (1) NZ539229A (es)
OA (1) OA12940A (es)
PA (1) PA8584201A1 (es)
PE (1) PE20040507A1 (es)
PT (1) PT1556414E (es)
RS (1) RS20050274A (es)
RU (1) RU2332424C2 (es)
SI (1) SI1556414T1 (es)
SV (1) SV2004001626A (es)
TN (1) TNSN05101A1 (es)
TW (1) TWI332010B (es)
UA (1) UA81925C2 (es)
UY (1) UY28016A1 (es)
WO (1) WO2004033503A1 (es)
ZA (1) ZA200502787B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2845686B1 (fr) * 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
FR2857971B1 (fr) * 2003-07-24 2005-08-26 Aventis Pharma Sa Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
WO2007140231A2 (en) * 2006-05-25 2007-12-06 Momenta Pharmaceutical, Inc. Low molecular weight heparin composition and uses thereof
WO2008068854A1 (ja) 2006-12-05 2008-06-12 Glycoscience Laboratories, Inc. 変形性関節症の治療剤
CN102300870B (zh) 2009-02-02 2014-12-03 大塚化学株式会社 低分子量多硫酸化透明质酸衍生物和含有它的医药
EP2233145A1 (en) 2009-03-19 2010-09-29 Sanofi-Aventis A dose of AVE5026 for the treatment of venous thromboembolism in patients with severe renal impairment
EP2399590A1 (en) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin for the prevention of a mortality and/or morbidity event in a patient undergoing major orthopaedic surgery
EP2399592A1 (en) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin for use as an antithrombotic treatment in hip replacement surgery with improved safety in terms of clinically relevant bleedings and major bleedings
EP2399591A1 (en) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin for the extended prevention of a mortality and/or morbidity event in a patient having undergone hip fracture surgery
EP2399593A1 (en) 2010-06-28 2011-12-28 Aventis Pharma S.A. Semuloparin for use as an antithrombotic treatment in orthopaedic surgery with improved benefit-risk profile
JP2012046511A (ja) * 2010-07-30 2012-03-08 Otsuka Chem Co Ltd 低分子量多硫酸化ヒアルロン酸誘導体を含有する医薬
WO2012036152A1 (ja) * 2010-09-14 2012-03-22 国立大学法人 宮崎大学 高純度ヘパリンおよびその製造方法
WO2012055843A1 (en) 2010-10-28 2012-05-03 Aventis Pharma S.A. Semuloparin for the prevention of major venous thromboembolism in a patient undergoing major abdominal surgery
EP2446891A1 (en) 2010-10-28 2012-05-02 Aventis Pharma S.A. Semuloparin for use as an antithrombotic treatment in major abdominal surgery with improved safety in terms of clinically relevant bleedings and major bleedings
WO2012072799A1 (en) 2010-12-02 2012-06-07 Aventis Pharma S.A. New methods for the in vitro measurement of the biological activity of an ultra low molecular weight heparin sample
AR085961A1 (es) * 2011-04-11 2013-11-06 Sanofi Sa Polisacaridos que poseen dos sitios de union a la antitrombina iii, metodo para prepararlos y composiciones farmaceuticas que los contienen
EP2548561A1 (en) 2011-07-22 2013-01-23 Aventis Pharma S.A. Semuloparin for improving the survival of patients with locally advanced cancer
WO2013044793A1 (zh) * 2011-09-26 2013-04-04 Xu Meiying 一种高纯度肝素苄酯盐及其制法和应用
CN102633908A (zh) * 2012-05-02 2012-08-15 雷晓刚 一种高品质超低分子量肝素的制备方法
ES2445494B1 (es) * 2012-08-02 2015-03-06 Rovi Lab Farmaceut Sa Procedimiento de obtención de heparinas de bajo y muy bajo peso molecular
US9873712B2 (en) * 2014-10-03 2018-01-23 Amphastar Pharmaceuticals, Inc. Method of purifying idraparinux sodium
JP6741277B2 (ja) * 2015-12-30 2020-08-19 シェンツェン ヘパリンク ファーマスーティカル グループ カンパニー リミテッドShenzhen Hepalink Pharmaceutical Group Co., Ltd. 硫酸化ヘパリン由来オリゴ糖及びその調製法と施用
CZ308106B6 (cs) * 2016-06-27 2020-01-08 Contipro A.S. Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití
CN110917208B (zh) * 2019-12-27 2021-02-12 浙江医院 硫酸化甘露葡萄糖醛酸六糖在防治动脉粥样硬化中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
FR2482611B1 (fr) * 1980-05-14 1986-03-07 Pharmindustrie Nouveaux polysaccharides sulfates, procedes pour leur preparation et leur utilisation comme medicaments
FR2504928A1 (fr) * 1981-04-29 1982-11-05 Choay Sa Oligosaccharides a chaines courtes possedant des proprietes biologiques, leur preparation et leurs applications en tant que medicaments
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
FR2584606A1 (fr) * 1985-07-12 1987-01-16 Dropic Utilisation de poly- et oligosaccharides pour l'obtention de medicaments actifs dans les pathologies du tissu conjonctif
JP4897991B2 (ja) * 1999-07-23 2012-03-14 ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ 超低分子量ヘパリン組成物
ES2161615B1 (es) * 1999-07-23 2003-03-16 Rovi Lab Farmaceut Sa Composiciones de heparinas de muy bajo peso molecular.
FR2807043B1 (fr) * 2000-03-28 2002-11-22 Aventis Pharma Sa Composition pharmaceutique contenant des oligosaccharides, les nouveaux oligosaccharides et leur preparation
FR2811992B1 (fr) * 2000-07-21 2003-07-04 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
FR2845686B1 (fr) * 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
AU2003300161B2 (en) 2009-08-27
PE20040507A1 (es) 2004-10-13
NI200300087A (es) 2012-02-02
TWI332010B (en) 2010-10-21
HN2003000312A (es) 2005-10-20
IL167868A (en) 2010-05-31
SI1556414T1 (sl) 2012-06-29
JP5021898B2 (ja) 2012-09-12
GT200300181A (es) 2004-03-24
EP1556414A1 (fr) 2005-07-27
ES2383597T3 (es) 2012-06-22
CN101812189A (zh) 2010-08-25
OA12940A (fr) 2006-10-13
ATE548393T1 (de) 2012-03-15
MY142376A (en) 2010-11-30
RU2332424C2 (ru) 2008-08-27
PT1556414E (pt) 2012-05-21
CA2501546C (fr) 2012-04-03
TNSN05101A1 (fr) 2007-05-14
SV2004001626A (es) 2004-03-08
CY1112808T1 (el) 2016-02-10
RS20050274A (en) 2007-06-04
CN101817940A (zh) 2010-09-01
FR2845686B1 (fr) 2013-08-30
ZA200502787B (en) 2005-10-18
WO2004033503A1 (fr) 2004-04-22
MXPA05003321A (es) 2005-07-05
JP2006517185A (ja) 2006-07-20
BR0315149A (pt) 2005-08-16
TW200418882A (en) 2004-10-01
NO20052170L (no) 2005-07-07
CA2501546A1 (fr) 2004-04-22
CN1798771A (zh) 2006-07-05
JP5389140B2 (ja) 2014-01-15
MA27398A1 (fr) 2005-06-01
UA81925C2 (uk) 2008-02-25
FR2845686A1 (fr) 2004-04-16
NO20052170D0 (no) 2005-05-03
CN101810637A (zh) 2010-08-25
EP1556414B1 (fr) 2012-03-07
UY28016A1 (es) 2004-04-30
RU2005113987A (ru) 2006-01-27
CN101812139A (zh) 2010-08-25
CN101812190A (zh) 2010-08-25
DK1556414T3 (da) 2012-06-25
NZ539229A (en) 2008-03-28
JP2012051926A (ja) 2012-03-15
AU2003300161A1 (en) 2004-05-04
ECSP055722A (es) 2005-07-06

Similar Documents

Publication Publication Date Title
ECSP055722A (es) Mezclas de polisacaridos derivados de heparina, su preparacion y las composiciones farmaceuticas que las contienen
US4791195A (en) Novel oligosaccharides having pharmacological properties by depolymerization of heparin
Casu et al. Structural and conformational aspects of the anticoagulant and antithrombotic activity of heparin and dermatan sulfate
HRP20180124T1 (hr) Glikozaminoglikani koji nisu antikoagulanti koji sadrže ponavljajuću jedinicu disaharida i njihova medicinska upotreba
Franz et al. Structure-activity relationship of antithrombotic polysaccharide derivatives
Nishino et al. An anticoagulant fucoidan from the brown seaweed Ecklonia kurome
RU2010122324A (ru) Полисахаридные композиции, не обладающие антикоагулянтными свойствами
KR900018129A (ko) 콘드로이틴 황산염, 데르마탄황산염 및 히알루론산의 술포아미노 유도체와 그 약제학적 성질
Aspinall Carbohydrate polymers of plant cell walls
SI2794667T1 (en) Low anticoagulant heparins
EP0970130B1 (en) Glycosaminoglycans having high antithrombotic activity
AR029865A1 (es) Mezclas de polisacaridos sulfatados derivados de la heparina, su preparacion y las composiciones farmaceuticas que las contienen
IT1282994B1 (it) Derivati del polisaccaride k5 aventi elevata attivita' anticoagulante
NZ333721A (en) Pharmaceutically acceptable synthetic polysaccharides
HRP20230820T1 (hr) Heparan-sulfat, s visokom stopom 3-o-sulfatiranja u glukozaminskim ostacima
JP3218039B2 (ja) 硫酸化多糖類,それらの調製法,医薬組成物および使用
Scott et al. Detection of secondary structure in glycosaminoglycans via the1H nmr signal of the acetamido NH group
JP2004210715A5 (es)
DK0986580T3 (da) Oligosaccharidblandinger med antitrombotisk aktivitet
ITLO20130005A1 (it) Derivati di glucosamminoglicani n-desolfatati e loro uso come farmaci
PE20050246A1 (es) Mezclas de oligosacaridos derivados de la heparina, su preparacion y las composiciones farmaceuticas que las contienen
DE602004012314D1 (de) Niedermolekulare polysaccharide mit antithrombotischer wirkung
Franz et al. Novel pharmaceutical applications of polysaccharides
Sinaÿ Recent advances in the study of the binding site of heparin to antithrombin
Casu Structure, shape and function of glycosaminoglycans